In simple terms, JCR Pharmaceuticals Co., Ltd. has 124.801 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.748% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.189%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.130%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.052% return, is a testament to JCR Pharmaceuticals Co., Ltd.'s adeptness in optimizing resource deployment. JCR Pharmaceuticals Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.099%. Furthermore, the proficiency of JCR Pharmaceuticals Co., Ltd. in capital utilization is underscored by a remarkable 0.111% return on capital employed.
Stock Prices
JCR Pharmaceuticals Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $9.47, while its low point bottomed out at $9.47. This variance in figures offers investors a lucid insight into the roller-coaster ride that is JCR Pharmaceuticals Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing JCRRF liquidity ratios reveals its financial health of the firm.
The current ratio of 180.07% gauges short-term asset coverage for liabilities.
The quick ratio (108.36%) assesses immediate liquidity, while the cash ratio (57.34%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
180.07%
Quick Ratio
108.36%
Cash Ratio
57.34%
Profitability Ratios
JCRRF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 18.14% underscores its earnings before tax deductions.
The effective tax rate stands at 28.38%, revealing its tax efficiency.
The net income per EBT, 71.50%, and the EBT per EBIT, 95.81%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 18.93%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
18.14%
Effective Tax Rate
28.38%
Net Income per EBT
71.50%
EBT per EBIT
95.81%
EBIT per Revenue
18.93%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.80, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 254.08% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
108
Days of Inventory Outstanding
730
Operating Cycle
874.00
Days of Payables Outstanding
55
Cash Conversion Cycle
819
Receivables Turnover
2.54
Payables Turnover
6.64
Inventory Turnover
0.50
Fixed Asset Turnover
1.35
Asset Turnover
0.40
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 45.13, and free cash flow per share, 45.13, depict cash generation on a per-share basis.
The cash per share value, 146.64, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.14, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
45.13
Free Cash Flow per Share
45.13
Cash per Share
146.64
Operating Cash Flow Sales Ratio
0.14
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
0.24
Short Term Coverage Ratio
0.58
Dividend Payout Ratio
0.02
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 22.67%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.42, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 19.64%, and total debt to capitalization, 29.51%, ratios shed light on its capital structure.
An interest coverage of 105.82 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
22.67%
Debt Equity Ratio
0.42
Long Term Debt to Capitalization
19.64%
Total Debt to Capitalization
29.51%
Interest Coverage
105.82
Cash Flow to Debt Ratio
0.24
Company Equity Multiplier
1.85
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 276.27, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 30.34, reflects the portion of profit attributed to each share.
The book value per share, 419.61, represents the net asset value distributed per share, while the tangible book value per share, 392.25, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
276.27
Net Income Per Share
30.34
Book Value Per Share
419.61
Tangible Book Value Per Share
392.25
Shareholders Equity Per Share
419.61
Interest Debt Per Share
183.77
Capex Per Share
-68.86
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -32.77%, indicates top-line expansion, while the gross profit growth, -37.33%, reveals profitability trends.
EBIT growth, -75.04%, and operating income growth, -75.04%, offer insights into operational profitability progression.
The net income growth, -74.00%, showcases bottom-line expansion, and the EPS growth, -74.13%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-32.77%
Gross Profit Growth
-37.33%
EBIT Growth
-75.04%
Operating Income Growth
-75.04%
Net Income Growth
-74.00%
EPS Growth
-74.13%
EPS Diluted Growth
-74.12%
Weighted Average Shares Growth
0.47%
Weighted Average Shares Diluted Growth
0.51%
Dividends per Share Growth
25.68%
Operating Cash Flow Growth
-159.21%
Free Cash Flow Growth
-587.87%
10-Year Revenue Growth per Share
148.67%
5-Year Revenue Growth per Share
66.87%
3-Year Revenue Growth per Share
37.44%
10-Year Operating CF Growth per Share
-437.98%
5-Year Operating CF Growth per Share
-275.66%
3-Year Operating CF Growth per Share
-210.71%
10-Year Net Income Growth per Share
427.01%
5-Year Net Income Growth per Share
22.95%
3-Year Net Income Growth per Share
39.69%
10-Year Shareholders Equity Growth per Share
126.64%
5-Year Shareholders Equity Growth per Share
90.90%
3-Year Shareholders Equity Growth per Share
59.72%
10-Year Dividend per Share Growth per Share
631.64%
5-Year Dividend per Share Growth per Share
266.41%
3-Year Dividend per Share Growth per Share
174.66%
Receivables Growth
-28.54%
Inventory Growth
26.50%
Asset Growth
-2.26%
Book Value per Share Growth
2.03%
Debt Growth
25.97%
R&D Expense Growth
22.68%
SGA Expenses Growth
-13.57%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 181,724,288,021.347, captures the company's total value, considering both debt and equity.
Income quality, -1.02, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 3.85%, indicates the value of non-physical assets, and capex to operating cash flow, 155.64%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
181,724,288,021.347
Income Quality
-1.02
Research and Development to Revenue
25.63%
Intangibles to Total Assets
3.85%
Capex to Operating Cash Flow
155.64%
Capex to Revenue
-24.93%
Capex to Depreciation
-428.64%
Stock-Based Compensation to Revenue
0.50%
Graham Number
535.24
Return on Tangible Assets
4.13%
Graham Net Net
-95.34
Working Capital
12,040,000,000
Tangible Asset Value
48,760,000,000
Net Current Asset Value
5,277,000,000
Average Receivables
13,361,000,000
Average Payables
1,443,500,000
Average Inventory
16,575,000,000
Days Sales Outstanding
118
Days Payables Outstanding
64
Days of Inventory On Hand
760
ROIC
4.64%
ROE
0.07%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.82, and the price to book ratio, 1.82, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 2.45, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 17.99, and price to operating cash flows, 17.99, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
1.82
Price to Book Ratio
1.82
Price to Sales Ratio
2.45
Price Cash Flow Ratio
17.99
Enterprise Value Multiple
9.71
Price Fair Value
1.82
Price to Operating Cash Flow Ratio
17.99
Price to Free Cash Flows Ratio
17.99
Price to Tangible Book Ratio
3.30
Enterprise Value to Sales
5.29
Enterprise Value Over EBITDA
24.30
EV to Operating Cash Flow
-33.04
Earnings Yield
2.19%
Free Cash Flow Yield
-8.16%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
